Association of transient SIADH with sertraline.
Doshi
D
D
Borison
R
R
D015057:1-Naphthylamine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D002220:Carbamazepine / Q000009:adverse effects / Q000627:therapeutic use; D003866:Depressive Disorder / Q000188:drug therapy; D004359:Drug Therapy, Combination; D004361:Drug Tolerance; D006801:Humans; D007177:Inappropriate ADH Syndrome / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D020280:Sertraline
D015057:1-Naphthylamine; D002220:Carbamazepine; D017367:Selective Serotonin Reuptake Inhibitors; D020280:Sertraline